Collegium Pharmaceutical, Inc. (COLL)

Collegium Pharmaceutical Stock Forecast

Stock Price Forecast

The 5 analysts that cover Collegium Pharmaceutical stock have a consensus rating of "Strong Buy" and an average price target of $45.4, which forecasts a -3.26% decrease in the stock price over the next year. The lowest target is $37 and the highest is $50.

Price Target: $45.4 (-3.26%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$37	$45.4	$46	$50
Change	-21.16%	-3.26%	-1.98%	+6.54%

Analyst Ratings

The average analyst rating for Collegium Pharmaceutical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	4	3	3	3	4	4
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	4	4	4	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Les Sulewski Truist Securities	Truist Securities	Strong Buy Maintains $45 → $48	Strong Buy	Maintains	$45 → $48	+2.28%	Nov 7, 2025
Brandon Folkes HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $44 → $46	Strong Buy	Maintains	$44 → $46	-1.98%	Nov 7, 2025
Serge Belanger Needham	Needham	Strong Buy Reiterates $46	Strong Buy	Reiterates	$46	-1.98%	Oct 28, 2025
Brandon Folkes HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $44	Strong Buy	Initiates	$44	-6.24%	Aug 11, 2025
David Amsellem Piper Sandler	Piper Sandler	Hold Reiterates $36 → $37	Hold	Reiterates	$36 → $37	-21.16%	May 9, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

797.84M

Increased by 26.35%

from 631.45M

Revenue Next Year

827.14M

Increased by 3.67%

from 797.84M

EPS This Year

7.70

Increased by 314.97%

from 1.86

EPS Next Year

8.23

Increased by 6.85%

from 7.70

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	310.02M	276.87M	463.93M	566.77M	631.45M	797.84M	827.14M
Revenue Growth	4.49%	-10.69%	67.57%	22.17%	11.41%	26.35%	3.67%
EPS	0.76	1.86	-0.74	1.29	1.86	7.70	8.23
EPS Growth	-	144.25%	-	-	43.56%	314.97%	6.85%
Forward PE	-	-	-	-	-	6.09	5.70
No. Analysts	-	-	-	-	-	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	824.0M	868.4M
Avg	797.8M	827.1M
Low	763.8M	761.8M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	30.5%	8.8%
Avg	26.4%	3.7%
Low	21.0%	-4.5%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	7.98	10.59
Avg	7.70	8.23
Low	7.36	6.89

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	329.8%	37.4%
Avg	315.0%	6.9%
Low	296.4%	-10.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.